BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35949567)

  • 1. Inhaled nitric oxide for ECPELLA management in fulminant myocarditis complicated with severe right ventricular dysfunction: A case report.
    Oki T; Ikeda Y; Ishii S; Ako J
    J Cardiol Cases; 2022 Aug; 26(2):104-107. PubMed ID: 35949567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of inhaled nitric oxide in acute myocardial infarction complicated by right heart failure under ECPELLA support: case report.
    Fujita K; Ueno M; Yasuda M; Mizutani K; Miyoshi T; Nakazawa G
    Eur Heart J Case Rep; 2023 Aug; 7(8):ytad369. PubMed ID: 37575534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant use of VA-ECMO and Impella with inhaled nitric oxide to treat cardiogenic shock after cardiac surgery: A case report.
    Higashino A; Yahagi K; Taketani T; Miura S; Ohno T
    J Cardiol Cases; 2022 Nov; 26(5):333-335. PubMed ID: 36312780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venoarterial Extracorporeal Membrane Oxygenation With Concomitant Impella Versus Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock.
    Vallabhajosyula S; O'Horo JC; Antharam P; Ananthaneni S; Vallabhajosyula S; Stulak JM; Dunlay SM; Holmes DR; Barsness GW
    ASAIO J; 2020 May; 66(5):497-503. PubMed ID: 31335363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis Comparing Venoarterial Extracorporeal Membrane Oxygenation With or Without Impella in Patients With Cardiogenic Shock.
    Bhatia K; Jain V; Hendrickson MJ; Aggarwal D; Aguilar-Gallardo JS; Lopez PD; Narasimhan B; Wu L; Arora S; Joshi A; Tomey MI; Mahmood K; Qamar A; Birati EY; Fox A
    Am J Cardiol; 2022 Oct; 181():94-101. PubMed ID: 35999070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Venoarterial Extracorporeal Membrane Oxygenation and Percutaneous Left Ventricular Decompression Therapy with Impella Is Associated with Improved Outcomes in Refractory Cardiogenic Shock.
    Patel SM; Lipinski J; Al-Kindi SG; Patel T; Saric P; Li J; Nadeem F; Ladas T; Alaiti A; Phillips A; Medalion B; Deo S; Elgudin Y; Costa MA; Osman MN; Attizzani GF; Oliveira GH; Sareyyupoglu B; Bezerra HG
    ASAIO J; 2019 Jan; 65(1):21-28. PubMed ID: 29489461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A therapeutic concept to resolve a possible coronary desaturation under Ecpella support and maximize the potential for myocardial recovery: combination of veno-arteriovenous extracorporeal membrane oxygenation and Impella (VAVEcpella).
    Ushijima T; Sonoda H; Tanoue Y; Shiose A
    Perfusion; 2021 Jul; 36(5):535-537. PubMed ID: 32928072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of extracorporeal CPR with transcatheter heart pump support (ECPELLA) on improvement of short-term survival and neurological outcome in patients with refractory cardiac arrest - A single-site retrospective cohort study.
    Unoki T; Kamentani M; Nakayama T; Tamura Y; Konami Y; Suzuyama H; Inoue M; Yamamuro M; Taguchi E; Sawamura T; Nakao K; Sakamoto T
    Resusc Plus; 2022 Jun; 10():100244. PubMed ID: 35620182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-Care Ultrasound (POCUS)-Guided Management of Cardiogenic Shock in COVID-19 Fulminant Myocarditis With Combined Veno-Arterial Extracorporeal Membrane Oxygenation and Impella (ECPELLA): A Case Report.
    Kato S; Kurosaka E; Nakata K
    Cureus; 2024 May; 16(5):e60665. PubMed ID: 38774461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful weaning from veno-arterial ECMO and Impella2.5 by veno-venous and arterial ECMO (v-ECPELLA) for a patient with acute myocardial infarction complicated by severe lung injury.
    Shimizu S; Shimano M; Shibata Y; Hanaki Y; Kamiya H; Morimoto R; Okumura T; Murohara T
    J Cardiol Cases; 2020 Sep; 22(3):103-106. PubMed ID: 32884588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs. without left ventricular unloading by Impella: a systematic review and meta-analysis.
    Cappannoli L; Galli M; Zito A; Restivo A; Princi G; Laborante R; Vergallo R; Romagnoli E; Leone AM; Aurigemma C; Massetti M; Sanna T; Trani C; Burzotta F; Savarese G; Crea F; D'Amario D
    Eur Heart J Qual Care Clin Outcomes; 2023 Jun; 9(4):358-366. PubMed ID: 36370449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of veno-arterial extracorporeal membrane oxygenation combined with Impella (ECpella) therapy in acute coronary syndrome with cardiogenic shock.
    Shibasaki I; Masawa T; Abe S; Ogawa H; Takei Y; Tezuka M; Seki M; Kato T; Watanabe R; Koshiji N; Saitou S; Ogata K; Haruyama Y; Toyoda S; Fukuda H
    J Cardiol; 2022 Aug; 80(2):116-124. PubMed ID: 35288000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impella Motor Current Amplitude Reflects the Degree of Left Ventricular Unloading under ECPELLA Support.
    Unoki T; Saku K; Kametani M; Konami Y; Taguchi E; Sawamura T; Nakao K; Sakamoto T
    Int Heart J; 2022; 63(6):1187-1193. PubMed ID: 36450558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of ECPELLA on haemodynamics and global oxygen delivery: a comprehensive simulation of biventricular failure.
    Matsushita H; Saku K; Nishikawa T; Yokota S; Sato K; Morita H; Yoshida Y; Fukumitsu M; Uemura K; Kawada T; Yamaura K
    Intensive Care Med Exp; 2024 Feb; 12(1):13. PubMed ID: 38361021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Management of ECPELLA.
    Nakamura M; Imamura T
    Int Heart J; 2020 Nov; 61(6):1094-1096. PubMed ID: 33116023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hypoxemia caused by Impella in a patient with fulminant myocarditis and patent foramen ovale.
    Shibao K; Murasato Y; Araki M; Tayama E; Fukumoto Y
    J Cardiol Cases; 2023 Jan; 27(1):36-40. PubMed ID: 36618839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ECMO vs ECpella in Patients With Non-Post-Pericardiotomy Cardiogenic Shock: An Updated Meta-Analysis.
    Iannaccone M; Venuti G; di Simone E; De Filippo O; Bertaina M; Colangelo S; Boccuzzi G; de Piero ME; Attisani M; Barbero U; Zanini P; Livigni S; Noussan P; D'Ascenzo F; de Ferrari GM; Porto I; Truesdell AG
    Cardiovasc Revasc Med; 2022 Jul; 40():134-141. PubMed ID: 34654655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of concomitant use of veno-arterial extracorporeal membrane oxygenation support with Impella in cardiogenic shock: From percutaneous femoral Impella to axillary Impella 5.5.
    Isath A; Ohira S; Levine A; Lanier GM; Pan S; Aggarwal-Gupta C; Mason I; Gregory V; Spielvogel D; Gass AL; Kai M
    Artif Organs; 2023 Aug; 47(8):1404-1412. PubMed ID: 37335815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impella as unloading strategy during VA-ECMO: systematic review and meta-analysis.
    Fiorelli F; Panoulas V
    Rev Cardiovasc Med; 2021 Dec; 22(4):1503-1511. PubMed ID: 34957789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular unloading via percutaneous assist device during extracorporeal membrane oxygenation in acute myocardial infarction and cardiac arrest.
    Kieserman JM; Kuznetsov IA; Park J; Schurr JW; Toubat O; Olia S; Bermudez C; Cevasco M; Wald J
    Int J Artif Organs; 2024 Jun; ():3913988241254978. PubMed ID: 38853663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.